Cost-effectiveness of baloxavir marboxil compared with laninamivir for the treatment of influenza in patients at high risk for complications in Japan

导出原文传递

翻译打印收藏纠错

作者： Dronova, Mariia ^[1] ; Ikeoka, Hidetoshi ^[2] ; Itsumura, Naoya ^[3] ; Hirotsu, Nobuo ^[4] ; Ansaripour, Amir ^[5] ; Aballea, Samuel ^[6] ; Onishi, Yoshie ^[7] ; Hill, Mark ; Igarashi, Ataru

作者单位： Shionogi & Co Ltd, Osaka, Japan ^[1] Hirotsu Clin, Kawasaki, Kanagawa, Japan ^[2] Grad Sch Pharmaceut Sci, Dept Drug Policy & Management, Tokyo, Japan ^[3] Creat Ceut, Rotterdam, Netherlands ^[4] Shionogi & Co Ltd, London, England ^[5] Creat Ceut, Tokyo, Japan ^[6] Creat Ceut, Przemyslowa 12, PL-30701 Krakow, Poland ^[7]

关键词 Baloxavir marboxil laninamivir antiviral influenza cost-effectiveness analysis high risk for complications

发布时间 2021-09-07

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交